Holly P. McEwen

591 total citations
9 papers, 214 citations indexed

About

Holly P. McEwen is a scholar working on Molecular Biology, Neurology and Physiology. According to data from OpenAlex, Holly P. McEwen has authored 9 papers receiving a total of 214 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 2 papers in Neurology and 2 papers in Physiology. Recurrent topics in Holly P. McEwen's work include Sphingolipid Metabolism and Signaling (3 papers), Neurogenesis and neuroplasticity mechanisms (2 papers) and Neuroinflammation and Neurodegeneration Mechanisms (2 papers). Holly P. McEwen is often cited by papers focused on Sphingolipid Metabolism and Signaling (3 papers), Neurogenesis and neuroplasticity mechanisms (2 papers) and Neuroinflammation and Neurodegeneration Mechanisms (2 papers). Holly P. McEwen collaborates with scholars based in Australia, Germany and United Kingdom. Holly P. McEwen's co-authors include Anthony S. Don, Ivan Lukmantara, Ximing Du, Yiqiong Yuan, Sarah E. Hancock, Elvis Pandžić, Shiqian Qi, Hoi Yin Mak, Hongyuan Yang and Renée Whan and has published in prestigious journals such as Journal of Neuroscience, The Journal of Cell Biology and Journal of Neurochemistry.

In The Last Decade

Holly P. McEwen

9 papers receiving 213 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Holly P. McEwen Australia 7 108 58 49 40 21 9 214
Peter W. Halcrow United States 11 121 1.1× 51 0.9× 86 1.8× 34 0.8× 20 1.0× 21 317
Johanna Rankenberg United States 11 230 2.1× 60 1.0× 17 0.3× 31 0.8× 10 0.5× 22 353
Patrick Niekamp United States 4 186 1.7× 48 0.8× 55 1.1× 52 1.3× 5 0.2× 7 270
Emma R. Perri Australia 8 115 1.1× 142 2.4× 51 1.0× 41 1.0× 22 1.0× 9 288
Theodora Saridaki Germany 11 120 1.1× 65 1.1× 58 1.2× 101 2.5× 22 1.0× 11 397
Waka Kojima Japan 7 171 1.6× 57 1.0× 173 3.5× 51 1.3× 19 0.9× 12 304
Vaibhavi Kadam Canada 5 167 1.5× 44 0.8× 13 0.3× 72 1.8× 7 0.3× 9 237
Atsuko Ohashi Japan 11 188 1.7× 30 0.5× 33 0.7× 43 1.1× 11 0.5× 23 307
François Le Guerroué United States 7 174 1.6× 80 1.4× 143 2.9× 32 0.8× 10 0.5× 9 320
Shady Saad Switzerland 7 311 2.9× 81 1.4× 22 0.4× 50 1.3× 8 0.4× 10 363

Countries citing papers authored by Holly P. McEwen

Since Specialization
Citations

This map shows the geographic impact of Holly P. McEwen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holly P. McEwen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holly P. McEwen more than expected).

Fields of papers citing papers by Holly P. McEwen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Holly P. McEwen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holly P. McEwen. The network helps show where Holly P. McEwen may publish in the future.

Co-authorship network of co-authors of Holly P. McEwen

This figure shows the co-authorship network connecting the top 25 collaborators of Holly P. McEwen. A scholar is included among the top collaborators of Holly P. McEwen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Holly P. McEwen. Holly P. McEwen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Zhang, Yunwei, Dylan Harney, Holly P. McEwen, et al.. (2025). Left ventricular myocardial molecular profile of human diabetic ischaemic cardiomyopathy. EMBO Molecular Medicine. 17(9). 2483–2524. 1 indexed citations
2.
Teo, Jonathan D., Alanna G. Spiteri, Holly P. McEwen, et al.. (2022). Early microglial response, myelin deterioration and lethality in mice deficient for very long chain ceramide synthesis in oligodendrocytes. Glia. 71(4). 1120–1141. 20 indexed citations
3.
Staudt, Dilana E., Heather C. Murray, David A. Skerrett‐Byrne, et al.. (2022). Phospho-heavy-labeled-spiketide FAIMS stepped-CV DDA (pHASED) provides real-time phosphoproteomics data to aid in cancer drug selection. Clinical Proteomics. 19(1). 48–48. 2 indexed citations
4.
Sheedy, Donna, et al.. (2021). Lipidome changes in alcohol‐related brain damage. Journal of Neurochemistry. 160(2). 271–282. 6 indexed citations
5.
Wang, Yi-Chang, Ximing Du, Hoi Yin Mak, et al.. (2021). TMEM41B and VMP1 are scramblases and regulate the distribution of cholesterol and phosphatidylserine. The Journal of Cell Biology. 220(6). 119 indexed citations
6.
McEwen, Holly P., et al.. (2021). Sphingosine kinase 2 is essential for remyelination following cuprizone intoxication. Glia. 69(12). 2863–2881. 16 indexed citations
7.
Swapna, Lingam Amara, Yen Chin Koay, Holly P. McEwen, et al.. (2021). Multi-omics of a pre-clinical model of diabetic cardiomyopathy reveals increased fatty acid supply impacts mitochondrial metabolic selectivity. Journal of Molecular and Cellular Cardiology. 164. 92–109. 7 indexed citations
8.
Teo, Jonathan D., Holly P. McEwen, Jun Yup Lee, et al.. (2019). Sphingosine Kinase 2 Potentiates Amyloid Deposition but Protects against Hippocampal Volume Loss and Demyelination in a Mouse Model of Alzheimer's Disease. Journal of Neuroscience. 39(48). 9645–9659. 23 indexed citations
9.
McEwen, Holly P., Eric Y. Du, Jitendra Mata, Pall Thordarson, & Adam D. Martin. (2017). Tuning hydrogels through metal-based gelation triggers. Journal of Materials Chemistry B. 5(47). 9412–9417. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026